NEUROPATHOLOGY OF IMMUNOHISTOCHEMICALLY IDENTIFIED BRAIN-STEM NEURONS IN PARKINSONS-DISEASE

被引:322
作者
HALLIDAY, GM
LI, YW
BLUMBERGS, PC
JOH, TH
COTTON, RGH
HOWE, PRC
BLESSING, WW
GEFFEN, LB
机构
[1] ROYAL CHILDRENS HOSP, MURDOCH INST, PARKVILLE, VIC 3052, AUSTRALIA
[2] CSIRO, DIV HUMAN NUTR, ADELAIDE, SA, AUSTRALIA
[3] FLINDERS UNIV, MED CTR, CTR NEUROSCI, BEDFORD PK, SA 5042, AUSTRALIA
[4] INST MED & VET SCI, DEPT NEUROPATHOL, ADELAIDE, SA 5000, AUSTRALIA
[5] CORNELL UNIV, MED CTR, COLL MED, MOLEC NEUROBIOL LAB, NEW YORK, NY 10021 USA
关键词
D O I
10.1002/ana.410270405
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Regional loss of immunohistochemically identified neurons in serial sections through the brainstem of 4 patients with idiopathic Parkinson's disease was compared with equivalent sections from 4 age‐matched control subjects. In the Parkinson brains, the catecholamine cell groups of the midbrain, pons, and medulla showed variable neuropathological changes. All dopaminergic nuclei were variably affected, but were most severely affected in the caudal, central substantia nigra. The pontine noradrenergic locus ceruleus showed variable degrees of degeneration. There was also a substantial loss of substance P–containing neurons in the pedunculopontine tegmental nucleus. However, the most severely affected cell group in the pons was the serotonin‐synthesizing neurons in the median raphe. In the medulla, substantial neuronal loss was found in several diverse cell groups including the adrenaline‐synthesizing and neuropeptide Y–containing neurons in the rostral ventrolateral medulla, the serotonin‐synthesizing neurons in the raphe obscurus nucleus, the substance P–containing neurons in the lateral reticular formation, as well as the substance P–containing neurons in the dorsal motor vagal nucleus. Lewy bodies were present in immunohistochemically identified neurons in many of these regions, indicating that they were affected directly by the disease process. These widespread but region‐ and transmitter‐specific changes help account for the diversity of motor, cognitive, and autonomic manifestations of Parkinson''s disease. Copyright © 1990 American Neurological Association
引用
收藏
页码:373 / 385
页数:13
相关论文
共 51 条
[31]   DOPAMINERGIC NEUROTRANSMITTER SYSTEMS IN ALZHEIMERS-DISEASE AND IN DOWNS-SYNDROME AT MIDDLE-AGE [J].
MANN, DMA ;
YATES, PO ;
MARCYNIUK, B .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1987, 50 (03) :341-344
[32]   THE TOPOGRAPHY OF CELL LOSS FROM LOCUS-CERULEUS IN ALZHEIMERS-DISEASE [J].
MARCYNIUK, B ;
MANN, DMA ;
YATES, PO .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1986, 76 (2-3) :335-345
[33]   DECREASE OF SUBSTANCE-P-LIKE IMMUNOREACTIVITY IN THE SUBSTANTIA NIGRA AND PALLIDUM OF PARKINSONIAN BRAINS [J].
MAUBORGNE, A ;
JAVOYAGID, F ;
LEGRAND, JC ;
AGID, Y ;
CESSELIN, F .
BRAIN RESEARCH, 1983, 268 (01) :167-170
[34]   CATECHOLAMINE NEURONS WITH ALZHEIMERS NEUROFIBRILLARY CHANGES AND ALTERATION OF TYROSINE-HYDROXYLASE - IMMUNOHISTOCHEMICAL INVESTIGATION OF TYROSINE-HYDROXYLASE [J].
NAKASHIMA, S ;
IKUTA, F .
ACTA NEUROPATHOLOGICA, 1985, 66 (01) :37-41
[35]   PARKINSONS-DISEASE - DISTRIBUTION OF LEWY BODIES AND MONOAMINE NEURON SYSTEM [J].
OHAMA, E ;
IKUTA, F .
ACTA NEUROPATHOLOGICA, 1976, 34 (04) :311-319
[36]  
Olszewski J., 1982, CYTOARCHITECTURE HUM, V2nd Edn
[37]  
PAKKENBERG H., 1965, ACTA NEUROPATHOL, V5, P320
[38]  
Paxinos G., 1986, BRAIN NAVIGATOR, Vsecond
[39]   HUMAN BRAIN-STEM CATECHOLAMINE NEURONAL ANATOMY AS INDICATED BY IMMUNOCYTOCHEMISTRY WITH ANTIBODIES TO TYROSINE-HYDROXYLASE [J].
PEARSON, J ;
GOLDSTEIN, M ;
MARKEY, K ;
BRANDEIS, L .
NEUROSCIENCE, 1983, 8 (01) :3-32
[40]   DEGENERATION OF NORADRENERGIC AND SEROTONERGIC BUT NOT DOPAMINERGIC-NEURONS IN THE LUMBAR SPINAL-CORD OF PARKINSONIAN-PATIENTS [J].
SCATTON, B ;
DENNIS, T ;
LHEUREUX, R ;
MONFORT, JC ;
DUYCKAERTS, C ;
JAVOYAGID, F .
BRAIN RESEARCH, 1986, 380 (01) :181-185